These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10751814)

  • 1. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease.
    Kuruvilla A; Costa JL; Wright RB; Yoder DM; Andriacchi TP
    Neurol India; 2000 Mar; 48(1):49-55. PubMed ID: 10751814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics of gait in Charcot-Marie-Tooth disease types I and II.
    Newman CJ; Walsh M; O'Sullivan R; Jenkinson A; Bennett D; Lynch B; O'Brien T
    Gait Posture; 2007 Jun; 26(1):120-7. PubMed ID: 17010610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive evaluation of the variation in ankle function during gait in children and youth with Charcot-Marie-Tooth disease.
    Õunpuu S; Garibay E; Solomito M; Bell K; Pierz K; Thomson J; Acsadi G; DeLuca P
    Gait Posture; 2013 Sep; 38(4):900-6. PubMed ID: 23702343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast responses to stepping on an unexpected surface height depend on intact large-diameter nerve fibers: a study on Charcot-Marie-Tooth type 1A disease.
    van der Linden MH; de Kam D; van Engelen BG; Hendricks HT; Duysens J
    J Neurophysiol; 2009 Sep; 102(3):1684-98. PubMed ID: 19625532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients.
    Don R; Serrao M; Vinci P; Ranavolo A; Cacchio A; Ioppolo F; Paoloni M; Procaccianti R; Frascarelli F; De Santis F; Pierelli F; Frascarelli M; Santilli V
    Clin Biomech (Bristol, Avon); 2007 Oct; 22(8):905-16. PubMed ID: 17686557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease.
    Lewis RA; Li J; Fuerst DR; Shy ME; Krajewski K
    Muscle Nerve; 2003 Aug; 28(2):161-7. PubMed ID: 12872319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot-Marie-Tooth type X: A novel mutation in the Cx32 gene with central conduction slowing.
    Seeman P; Mazanec R; Ctvrtecková M; Smilková D
    Int J Mol Med; 2001 Oct; 8(4):461-8. PubMed ID: 11562788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.
    Miltenberger-Miltenyi G; Janecke AR; Wanschitz JV; Timmerman V; Windpassinger C; Auer-Grumbach M; Löscher WN
    Arch Neurol; 2007 Jul; 64(7):966-70. PubMed ID: 17620486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Charcot-Marie-Tooth disease. Gait analysis and electrophysiologic, genetic, histopathologic, and enzyme studies in a kinship.
    Sabir M; Lyttle D
    Clin Orthop Relat Res; 1984 Apr; (184):223-35. PubMed ID: 6705352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease.
    Martel J; Mierau D; Donat J
    J Manipulative Physiol Ther; 1995; 18(3):168-71. PubMed ID: 7790797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gait patterns and functional measures between Charcot-Marie-Tooth disease type I and II in children to young adults.
    Pogemiller K; Garibay E; Pierz K; Acsadi G; Õunpuu S
    Gait Posture; 2020 Mar; 77():236-242. PubMed ID: 32062403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of compensatory gait in persons with myelomeningocele.
    Gutierrez EM; Bartonek A; Haglund-Akerlind Y; Saraste H
    Gait Posture; 2005 Jan; 21(1):12-23. PubMed ID: 15536030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of range of motion in dorsiflexion, when the triceps surae muscles weaken, worsens stance and gait in Charcot-Marie-Tooth disease. A case report.
    Vinci P
    Eura Medicophys; 2006 Sep; 42(3):219-22. PubMed ID: 17039218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gait analysis in a patient with severe Charcot-Marie-Tooth disease: a case study with a new orthotic device for footdrop.
    Vinci P; Paoloni M; Ioppolo F; Gargiulo P; Santilli V
    Eur J Phys Rehabil Med; 2010 Sep; 46(3):355-61. PubMed ID: 20927001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare myelin protein zero sequence variant in late onset CMT1B.
    Souayah N; Seltzer WK; Brannagan TH; Chin RL; Sander HW
    J Neurol Sci; 2007 Dec; 263(1-2):177-9. PubMed ID: 17602703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure characteristics in painful pes cavus feet resulting from Charcot-Marie-Tooth disease.
    Crosbie J; Burns J; Ouvrier RA
    Gait Posture; 2008 Nov; 28(4):545-51. PubMed ID: 18456499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using induced accelerations to understand knee stability during gait of individuals with muscle weakness.
    Siegel KL; Kepple TM; Stanhope SJ
    Gait Posture; 2006 Jun; 23(4):435-40. PubMed ID: 16098747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.